Affiliation:
1. Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt
2. Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan
Abstract
Sofosbuvir (SOF), a nucleos(t)ide polymerase inhibitor, has been used during the past decade for mass treatment of viral hepatitis C in endemic countries like Egypt, increasing the exposure of women at childbearing age to SOF. This study investigated the long-lasting consequences of the pre-conceptional exposure of young female rats to SOF on the ovarian tissues of F1 offspring and explored the possible molecular mechanisms of these intergenerational effects at various levels. The study was conducted on young female rats that were divided into control group and SOF-exposed group at a dose of 4 mg/kg/day for three months. After that, pregnancy was induced in both groups by mating with healthy male rats. After delivery, the female neonates were followed for 4 months, and the ovarian tissues were collected to assess the studied parameters. Pre-conceptional exposure to SOF affected the ovarian functions of F1 offspring through modulation of estrogen receptors, ovarian Kiss1 and its receptor, increased lipid peroxidation marker, DNA oxidation marker, and redox-sensitive nuclear factor kappa B, and decreased nuclear erythroid-2-related factor 2, mitochondrial function, and biogenesis. SOF affected the ovarian function of the F1 offspring by inducing oxidative stress and inflammation, leading to the modulation of mitochondrial functions and biogenesis.
Funder
Science and Technology Development Fund
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference48 articles.
1. World Health Organization [WHO] (2021). Accelerating Access to Hepatitis C Diagnostics and Treatment: Overcoming Barriers in Low-and Middle-Income Countries: Global Progress Report 2020, WHO.
2. World Health Organization [WHO] (2022). Updated Recommendations on Simplified Service Delivery and Disagnostics for Hepititis C Infection: Policy Brief, WHO.
3. Direct-acting antivirals for the treatment of hepatitis C virus infection: Optimizing current IFN-free treatment and future perspectives;Asselah;Liver Int.,2016
4. Ginsenoside Rg3 restores hepatitis C virus–induced aberrant mitochondrial dynamics and inhibits virus propagation;Kim;Hepatology,2017
5. Impact of pharmacological agents on mitochondrial function: A growing opportunity?;Stoker;Biochem. Soc. Trans.,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献